First Time Loading...

ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 2.01 USD 1.01% Market Closed
Updated: May 5, 2024

ProQR Therapeutics NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ProQR Therapeutics NV
Revenue Peer Comparison

Comparables:
PHARM
QURE
ARGX
MRUS
N
NAMS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ProQR Therapeutics NV
NASDAQ:PRQR
Revenue
€9.5m
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Revenue
$245.3m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
43%
Uniqure NV
NASDAQ:QURE
Revenue
$15.8m
CAGR 3-Years
-25%
CAGR 5-Years
7%
CAGR 10-Years
14%
argenx SE
XBRU:ARGX
Revenue
$1.2B
CAGR 3-Years
210%
CAGR 5-Years
121%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Revenue
$43.9m
CAGR 3-Years
14%
CAGR 5-Years
3%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Revenue
€97.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ProQR Therapeutics NV's Revenue?
Revenue
9.5m EUR

Based on the financial report for Dec 31, 2023, ProQR Therapeutics NV's Revenue amounts to 9.5m EUR.

What is ProQR Therapeutics NV's Revenue growth rate?
Revenue CAGR 5Y
11%

Over the last year, the Revenue growth was 98%.